The frequency of AR expression differs between breast cancer subtypes, varying from 85–95% in ER-positive (ER+) to 15–75% in ER-negative (ER−) breast tumors [18,19,20,21,22,23,24,25,26]. Here, ESR1 is linked to breast neoplasm.